Search Results
RxPONDER: sparing chemotherapy in node-positive early-stage breast cancer
RxPONDER: sparing chemotherapy in node-positive early-stage breast cancer
Kalinsky discusses results from RxPONDER breast cancer clinical trial
RxPONDER: 21-gene assay informs chemotherapy benefit in HR+ node-positive breast cancer
Node positive data - Exact Science
Can we decrease chemotherapy in LN+ premenopausal women based on genomic tests?
RxPONDER: is it all OFS?
Adjuvant Treatment for Early Stage Hormone Positive Breast Cancer: Role of Genomic Signatures
Advancements in Care for Early-stage Breast Cancer 2024
Dr. Chavez Mac Gregor on Chemotherapy in Node-Positive HR+/HER2- Breast Cancer
Omission of Chemotherapy Among Node-Positive Patients With ER+ Breast Cancer
New Study: Women With Early Stage Breast Cancer Can Skip Chemo